Crossmark

Incidence and spectrum of primary respiratory disease throughout the course of rheumatoid arthritis: implications of structured repeated evaluation for detection and risk-factor analysis

Crossref DOI link: https://doi.org/10.1186/s13075-026-03736-7

Published Online: 2026-01-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Aguilar-Coll, Martí https://orcid.org/0009-0007-2060-146X
Molina-Molina, María https://orcid.org/0000-0002-1852-1723
Robles-Pérez, Alejandro

Roig-Kim, Montserrat https://orcid.org/0009-0005-7874-6747
Bolivar, Santiago

del Río, Belén

Nolla, Joan Miquel https://orcid.org/0000-0002-2358-6767
Narváez, Javier https://orcid.org/0000-0002-1614-8064
License Information

Text and Data Mining valid from 2026-01-23

Version of Record valid from 2026-02-19
More Information

Article History

Received: 20 October 2025

Accepted: 10 January 2026

First Online: 23 January 2026

Declarations

:

: The study has been approved by of our institutional ethics committee (Clinical Research Ethics Committee of Bellvitge University Hospital-IDIBELL). The local ethics committee confirm that the findings in this report were based on normal clinical practice and were therefore suitable for dissemination. Informed consent was not obtained from the patients, but their clinical records and information were anonymised prior to analysis. Since our study was performed retrospectively, we were relieved by the ethics committee of our hospital from obtaining informed consent. This study was conducted in accordance with the principles of the Declaration of Helsinki and the International Conference for Harmonisation.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below